SRPT Q1 2018 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+295.3% YoY

Gross Profit

$59M91.4% margin

Operating Income

-$31M-47.6% margin

Net Income

-$35M-54.7% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

+12.8%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$49M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$524M

Stockholders' Equity

$777M

Cash & Equivalents

$557M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$16M	+295.3%
Gross Profit	$59M	$16M	+266.8%
Operating Income	-$31M	-$39M	+21.7%
Net Income	-$35M	$84M	-142.1%